Cisapride
Cat.No:IC4220 Solarbio
CAS:81098-60-4
Molecular Formula:C23H29ClFN3O4
Molecular Weight:465.95
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Neuronal Signal Pathway > CisaprideCAS:81098-60-4
Molecular Formula:C23H29ClFN3O4
Molecular Weight:465.95
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
| CAS | 81098-60-4 |
| Name | Cisapride |
| Molecular Formula | C23H29ClFN3O4 |
| Molecular Weight | 465.95 |
| Solubility | Soluble in DMSO(Need ultrasonic) |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| EC | EINECS 279-689-7 |
| MDL | MFCD03305346 |
| SMILES | COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F |
| InChIKey | DCSUBABJRXZOMT-IRLDBZIGSA-N |
| InChI | InChI=1S/C23H29ClFN3O4/c1-30-21-13-19(26)18(24)12-17(21)23(29)27-20-8-10-28(14-22(20)31-2)9-3-11-32-16-6-4-15(25)5-7-16/h4-7,12-13,20,22H,3,8-11,14,26H2,1-2H3,(H,27,29)/t20-,22+/m1/s1 |
| PubChem CID | 6917698 |
| Target Point | 5-HT Receptor |
| Passage | Neuronal Signaling;GPCR & G Protein |
| Background | It is a potent 5-HT4 receptor agonist and hERG inhibitor. |
| Biological Activity | Cisapride 是一种口服活性 5-HT4 受体激动剂,其 EC50 值为 140 nM。是一种 hERG 阻断剂,IC50 值为 9.4 nM。是一种胃动力药,可刺激胃肠道运动活动。[1-4] |
| IC50 | hERG channel: 9.4nM(IC50)[1] |
| Data Literature Source | [1]. Manabe N,et al. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders. Expert Opin Investig Drugs. 2010 Jun;19(6): 765-75. [2]. Sung KW,et al. Effect of mosapride on Kv4.3 potassium channels expressed in CHO cells. Naunyn Schmiedebergs Arch Pharmacol. 2013 Oct;386(10): 905-16. [3]. Mine Y,et al. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro. J Pharmacol Exp Ther. 1997 Dec;283(3): 1000-8. [4]. Motavallian A,et al. Does Cisapride,as a 5HT(4) Receptor Agonist,Aggravate the Severity of TNBS-Induced Colitis in Rat Gastroenterol Res Pract. 2012;2012: 362536. |
| Unit | Bottle |
| Specification | 10mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download